Antihyperglycemic drugs and cardiovascular outcomes in type 2 diabetes
The essential value of glycemic control in preventing microvascular and neuropathic complications was established in the Diabetes Control and Complications Trial (DCCT)1 and the United...
Source: Cleveland Clinic Journal of Medicine - Category: Journals (General) Tags: CCJM Supplement Articles CCJM Supplements CCJM Cardiology CCJM Diabetes Endocrinology & Metabolism Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | General Medicine | Heart | Neurology